Open Access

MicroRNA‑424 alleviates neurocyte injury by targeting PDCD4 in a cellular model of cerebral ischemic stroke

  • Authors:
    • Hou-Wei Ren
    • Bin Gu
    • Yue-Zhan Zhang
    • Ting Guo
    • Qian Wang
    • Yue-Qin Shen
    • Jun Wang
  • View Affiliations

  • Published online on: October 15, 2021     https://doi.org/10.3892/etm.2021.10888
  • Article Number: 1453
  • Copyright: © Ren et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cerebral ischemic stroke is the primary cause of stroke‑associated mortality and disability, and current therapeutic options are limited and ineffective. The present study aimed to investigate the potential of apoptotic therapy and the role of microRNA (miR)‑424 in cerebral ischemic stroke. PC12 cells, a cloned cell line from rat adrenal pheochromocytoma, were treated with CoCl2 to construct a cellular ischemia model. mRNA and protein levels of programmed cell death protein 4 (PDCD4), Bcl‑2, Bax, caspase‑3, PI3K and AKT were evaluated using reverse transcription‑quantitative PCR and western blot analyses, respectively. Cell Counting Kit‑8 assays were performed to examine cell viability in the ischemia model. Flow cytometry was conducted to evaluate the apoptosis of ischemic cells. Furthermore, a luciferase assay was performed to verify the target gene of miR‑424. It was revealed that the expression level of miR‑424 was downregulated in the ischemia model, while the expression of PDCD4 was upregulated. Moreover, the expression of miR‑424 was increased after treatment with miR‑424 mimics. The mRNA and protein expression of PDCD4 was upregulated after transfection with pcDNA3.1‑PDCD4. PDCD4 was predicted and demonstrated to be a target of miR‑424. Notably, overexpression of miR‑424 increased cell viability and inhibited apoptosis in the ischemia model, which was reversed by co‑treatment with pcDNA3.1‑PDCD4. Furthermore, overexpression of miR‑424 regulated the expression of PDCD4, Bax, Bcl‑2, phosphorylated‑PI3K/AKT and caspase‑3, which was restored after co‑transfection with pcDNA3.1‑PDCD4. Collectively, the results indicated that miR‑424 regulated the progression of cerebral ischemic stroke in a cellular model by targeting PDCD4.
View Figures
View References

Related Articles

Journal Cover

December-2021
Volume 22 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ren H, Gu B, Zhang Y, Guo T, Wang Q, Shen Y and Wang J: MicroRNA‑424 alleviates neurocyte injury by targeting PDCD4 in a cellular model of cerebral ischemic stroke. Exp Ther Med 22: 1453, 2021
APA
Ren, H., Gu, B., Zhang, Y., Guo, T., Wang, Q., Shen, Y., & Wang, J. (2021). MicroRNA‑424 alleviates neurocyte injury by targeting PDCD4 in a cellular model of cerebral ischemic stroke. Experimental and Therapeutic Medicine, 22, 1453. https://doi.org/10.3892/etm.2021.10888
MLA
Ren, H., Gu, B., Zhang, Y., Guo, T., Wang, Q., Shen, Y., Wang, J."MicroRNA‑424 alleviates neurocyte injury by targeting PDCD4 in a cellular model of cerebral ischemic stroke". Experimental and Therapeutic Medicine 22.6 (2021): 1453.
Chicago
Ren, H., Gu, B., Zhang, Y., Guo, T., Wang, Q., Shen, Y., Wang, J."MicroRNA‑424 alleviates neurocyte injury by targeting PDCD4 in a cellular model of cerebral ischemic stroke". Experimental and Therapeutic Medicine 22, no. 6 (2021): 1453. https://doi.org/10.3892/etm.2021.10888